Unicycive Therapeutics Director Laumas Sandeep Secures $1 M Worth of RSUs, Tripling His Stake Amid Clinical Milestone Hopes
Unicycive insiders’ new RSU grant signals confidence, tripling director Laumas Sandeep’s stake and hinting at future clinical gains amid current losses.
3 minutes to read